Close X
Monday, November 25, 2024
ADVT 
International

Man jailed for attacking elderly Sikh in Manchester

Darpan News Desk IANS, 11 Oct, 2022 05:09 PM
  • Man jailed for attacking elderly Sikh in Manchester

A man who had punched a 62-year-old Sikh in Manchester "without any justifiable reason" and left him for dead has been jailed for three years.

Claudio Campos, 28, attacked Avtar Singh in broad daylight as he was walking home from work through the Tib Street area of the City Centre on June 23.

Campos, who was with his partner at the time, proceeded to walk up behind Avtar before violently punching him to the head. Singh fell into the middle of the road where he stayed unconscious until a passer-by called for an ambulance.

Singh had suffered a severe traumatic brain injury, a stroke caused by bleeding on the brain and multiple fractures to his cheek, jaw and eye socket as a result of the attack, the BBC reported.

He remains in hospital requiring 24-hour nursing and medical care.

"This was a horrific attack on a much loved family member and community leader which deeply shocked the public. I hope today's verdict gives Mr. Singh's family some relief that the person who has harmed their husband and father has now faced justice and will be sent to prison," Detective Inspector Mark Astbury, of Greater Manchester Police (GMP), said.

Campos was located with the help of CCTV footage and taken into custody by the GMP in September, where he admitted the assault.

Sentencing Campos, Judge Hilary Manley told him he had attacked Singh "without any justifiable reason".

"As a direct result of your decision to attack him, his life, and the lives of his family, are forever traumatised, changed and diminished. He gave you no reason at all to do what you did," Manley was quoted as saying in the BBC.

The judge rejected the defendant's claim that he was "very sorry".

"When our dad came to this country over 30 years ago, he never imagined that he would be the subject of such a heinous attack which has left him bed bound and in hospital for as long as he has been," Singh's children said in a release issued by the GMP.

"As a family, we are truly heartbroken and still struggle to come to terms with the reality of his future and the truth behind this crime," they said.

MORE International ARTICLES

One person killed in shooting in Oakland

One person killed in shooting in Oakland
Police found the victim off the side of a road with apparent gunshot wounds. The man died from his injuries at the scene and his identity is being withheld until his next of kin is notified, the police said.

One person killed in shooting in Oakland

WHO calls on Pfizer to make its COVID pill more available

WHO calls on Pfizer to make its COVID pill more available
WHO Director-General Tedros Adhanom Ghebreyesus said during a news briefing that Pfizer's treatment was still too expensive. He noted that most countries in Latin America had no access to Pfizer’s drug, Paxlovid , which has been shown to cut the risk of COVID-19 hospitalization or death by up to 90%.    

WHO calls on Pfizer to make its COVID pill more available

Rare cases of COVID returning pose questions for Pfizer pill

Rare cases of COVID returning pose questions for Pfizer pill
Paxlovid has become the go-to option against COVID-19 because of its at-home convenience and impressive results in heading off severe disease. The U.S. government has spent more than $10 billion to purchase enough pills to treat 20 million people.    

Rare cases of COVID returning pose questions for Pfizer pill

CDC probing 109 liver illnesses in kids, including 5 deaths

CDC probing 109 liver illnesses in kids, including 5 deaths
About two dozen states reported suspected cases after the Centers for Disease Control and Prevention put out a call for doctors to be on the lookout for surprising cases of hepatitis. The cases date back to late October in children under 10. So far, only nine cases in Alabama have been confirmed.    

CDC probing 109 liver illnesses in kids, including 5 deaths

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

FDA restricts J&J's COVID-19 vaccine due to blood clot risk
FDA officials said in a statement that they decided to restrict J&J's vaccine after taking another look at data on the risk of life-threatening blood clots within two week of vaccination.

FDA restricts J&J's COVID-19 vaccine due to blood clot risk

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report
Preliminary research suggests it is about 25 per cent more transmissible than the BA.2 subvariant that is currently dominant nationally, according to the Centers for Disease Control and Prevention.

Omicron's latest subvariant BA.2.12.1 proves virus not declining: Report